IAN KROUSON: Open Payments
NPI 1790744381 · EAST GREENWICH, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,979 in 87 payments from 21 companies in 2025. Trend: 2023 $1,281 · 2024 $1,268 · 2025 $1,979
Food & beverage: $1,979
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $432 |
| AstraZeneca Pharmaceuticals LP | 13 | $264 |
| Novo Nordisk Inc | 6 | $179 |
| Indivior Inc. | 5 | $175 |
| Lundbeck LLC | 4 | $115 |
| PFIZER INC. | 6 | $114 |
| Amgen Inc. | 4 | $108 |
| Exact Sciences Corporation | 3 | $92 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| Merck Sharp & Dohme LLC | 3 | $64 |
Products named: SUBLOCADE, REXULTI, UBRELVY, VRAYLAR, OTEZLA, QULIPTA, FARXIGA, Cologuard Collection Kit.
Industry payments across RI — which companies pay providers there.
